Prevention of ovarian cancer by administration of progestin prod

Details Prevention of ovarian cancer by administration of progestin prod Prevention of ovarian cancer by administration of progestin prod

1996-09-13

2000-02-22

Robinson, Allen J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

A61K 3156

Patent

active

060280646

ABSTRACT:
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.

REFERENCES:
patent: 4757061 (1988-07-01), Faustini et al.
patent: 4760053 (1988-07-01), Labrie
patent: 4808578 (1989-02-01), Faustini et al.
patent: 4808616 (1989-02-01), Buzzetti et al.
patent: 4814327 (1989-03-01), Ottow et al.
patent: 4840943 (1989-06-01), Buzzetti et al.
patent: 4870069 (1989-09-01), Ottow et al.
patent: 4904650 (1990-02-01), Buzzetti et al.
patent: 4954790 (1990-09-01), Barber
patent: 5006518 (1991-04-01), Moguilewsky
patent: 5081114 (1992-01-01), Gourvest et al.
patent: 5086047 (1992-02-01), Gourvest et al.
patent: 5089488 (1992-02-01), Ottow et al.
patent: 5227375 (1993-07-01), Labrie et al.
patent: 5362720 (1994-11-01), Labrie
patent: 5364847 (1994-11-01), Labrie et al.
patent: 5434146 (1995-07-01), Labrie et al.
patent: 5461041 (1995-10-01), Bergink et al.
patent: 5486511 (1996-01-01), Weintraub et al.
patent: 5496813 (1996-03-01), Eugster et al.
patent: 5502044 (1996-03-01), Buzzetti et al.
Allgood, VE et al. "Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer," Biochemistry, 36(l):224-232 (1997).
Arends, MJ et al. "Apoptosis: Mechanisms and roles in pathology," Int Rev Exp Pathol, 32:223-254 (1991).
Arrick, BA et al. "Differential regulation of three transforming growth factor b species in human breast cancer cell lines by estradiol," Cancer Res., 50:299-303 (1990).
Bai, W et al. " Differential phosphorylation of chicken progesterone receptor in hormone-dependent and Ligand-independent activation," J Biol Chem, 272(16):10457-10463 (1997).
Bates, R.C. et al. "Involvement of integrins in cell survival," Cancer Metastasis Rev, 14(3):191-203 (1995).
Berchuck, A. et al., "Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth, factor-.beta.," Am J Obstet Gynecol, 166: 676-84 (1992).
Berchuck, A. et al., "The role of peptide growth factors in epithelial ovarian cancer," Obstet Gynecol, 75: 255-62 (1990).
Brenner, R.M. et al., "Cyclic changes in the primate oviduct and endometrium. In: Knobil E, Neill JD, eds. The Physiology of reproduction," New York: Raven Press, pp. 541-569 (1994).
Bu, SZ et al., "Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines," Cancer, 79: 1944-5.0 (1997).
Bundesverband der Pharmazeutishen Industrie, "Rote liste 1995," Ecv. Editio Cantor, Aulendorf(DE), pp. 75023-75024 (1995).
Chan, LN et al., "N-(4-hydroxyphenyl) retinamide prevents development of Tlymphomas in AKR/J mice," Anticancer Research, 17:499-503 (1997).
Cohen, J.J., "Apoptosis," Immun Today 14:126-130 (1993).
Delia, D. et al., "N-(4-hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid," Cancer Res., 53(24):603641 (1993).
Eguchi, Y. et al., "Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo," Nucleic Acids Research, 20(16) :4187-41922 (1992).
el-Bayoumy, K. et al., "Chemo prevention of cancer by organoselenium compounds," J Cell Biochem, Suppl., 22: 92-100 (1995).
Ellis, R. et al., "Mechanisms of cell death," Ann Rev Cell Bio, 17: 663-698 (1991).
Evans, D.L. et al., "Molecular evolution and secondary structural conservation in the B-cell lymphoma leukemia 2 (bcl-2) family of proto-oncogene products," J Mol Evol., 41(6):775-83 (1995).
Fredrickson, T.N. et al., "Ovarian tumors of the hen," Environ Health Perspect, 73:35-51(1987).
Gentry, L.E. et al., "Type I transforming growth factor-beta: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells," Mol Cell Biol, 7:3418-27 (1987).
Grimes et al., "Primary Prevention of Gynecologic Cancers," Am J. Obstetrics and Gynecology, 172(1):227-235 (1995).
Havrilesky, L.J. et al., "Regulation of Apoptosis in Normal and Malignant Ovarian Epithelial Cells by Transforming Growth Factor .beta.," Cancer Research, 55:944-948 (Feb. 15, 1995).
Hickey, M.J. et al., " Metabolic and Endocrinologic Effects of Steroidal Contraception Obstetrics," Ch 24, J. Sciarra, Editor, 1996 revised edition, Lippincott, Philadelphia, pp. 1-14 (1996).
Hotchkiss, J. et al., "The menstrual cycle and its neuroendocrine control," In: Knobil E, Neill JD, eds. The Physiology of Reproduction. New York: Raven Press, pp. 711-736 (1994).
Hurteau, J.A. et al., "Transforming growth factor-.beta. inhibits proliferation of human ovarian cancer cells obtained from ascites," Cancer, 74: 93-99 (1994).
Johnson, A.J. et al., "Expression of bcl-2 and nr-13 in hen ovarian Follicles during development," Biol Repro, 57: 1097-1103 (1997).
Kaiserman-Abramof, I. et al., "UItrastructural epithelial conation of the primate endometrium. (rhesus monkey)," Am J Anat, pp. 13-30 (1989).
Lingeman, C.H., "Etiology of cancer of the human ovary," A review, J Natl Cancer Inst, 53:1603-1618 (1974).
Lotan, R., "Retinoids in cancer chemo prevention," [Review] FASEB J., 10(9):1031-9, (1996).
Lumbiganon, P., "Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary," Contraception, 49:203-209 (Mar., 1994).
Mulheron, G.W. et al., "Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2 is regulated by gonadotropin in vitro," Endocrin, 129:368-3 73 (1991).
Mulheron, G.W. et al., "Rat granulosa cells express transforming growth factor-beta type 2 messenger ribonucleic acid which is regulatable by fillide stimulating hormone in vitro," Endocrin, 126: 1771-1779 (1990).
Mutch, D.G. et al., " Biology of epithelial ovarian cancer," Clin Obstet Gynecol, 37: 406-422 (1994).
O'Brien, V. et al., "Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation," Ex.Cell Res, 244(1):208-213 (1996).
Oberhammer, F.A. et al., "Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-.beta.1," Proc Natl. Acad Sci USA, 89:5408-5412 (1992).
Oridate, N. et al., "Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemo prevention," J Cell Biochem, Suppl, 23:80-6 (1995).
Pascale, R.M. et al., "Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promosted by orotic acid," Carcinogenesis 16(2):427-30 (1995).
Pfleiderer, "die Problematik einer prophylaktischen Chemotherapie, einer der Remission bei der Therapie des Ovarialkarzinoms," Geburstsh. u. Frauenheilk, 36(2):132-139 (1976).
Physician's Desk Reference 1996, Product Information, pp. 1871-1876 2136-2138 2601-2604 2759-2762 and 2813-2818 (1996).
Ponzoni, M. et al., "Differential effects of N-(4-hydroxyphenyl) retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation," Can Res., 55(4):853-61 (1995).
Qin, S. et al., "Cooperation of tyrosine kinases p72syk and p53/56lyn regulates calcium mobilization in chicken B cell oxidant stress signaling," Eur J Biochem, 236(2):443-9 (1996).
Rampalli, A.M. et al., "Insulin regulates expression of c-fos and c-jun and suppresses apoptosis of lens epithelial cells," Cell Growth Differ, 6(8):945-53 (1995).
Reddy, B.S. et al., "Chemo prevention of colon carcinogenesis by dietary perillyl alcohol," Cancer Res., 57(3):420-5 (1997).
Roberts, A.B. et al., "Mechanistic interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-.beta.," In: Cancer Surveys, vol. 14: Growth Regulation hy Nuclear Hormone Receptors, Imperial Cancer Research Fund, pp. 205-217 (1992).
Rodriguez, G.C. et al., "Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer.II. Relationship between receptor expression and response to epidermal growth factor," Am J Obstet Gynecol

Affiliated with

Also associated with

Rating

Prevention of ovarian cancer by administration of progestin prod does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of ovarian cancer by administration of progestin prod, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of ovarian cancer by administration of progestin prod will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-520648